ArticleScientific reports2026
Molecular characterization of extended-spectrum β-lactamase (ESBL) and virulent genes in multidrug-resistant Escherichia coli isolated from pharmaceutical and environmental Wastewaters in Dhaka, Bangladesh.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging and Underdetected Colonization Factors in EnterotoxigenicMicroorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidrug resistance poses a significant challenge to the efficacy of microbial infection treatment. Pharmaceuticals are significant reservoirs of antibiotic residues, which play a major role in inducing antibiotic-resistant microorganisms in wastewater. Antimicrobial resistance (AMR) among microorganisms present in pharmaceutical wastewater increases the threat of multidrug-resistant (MDR) bacteria, particularly in developing countries such as Bangladesh. This study investigates AMR in Escherichia coli isolated from effluent treatment plants (ETPs) and surrounding environmental water near six pharmaceutical sites in Dhaka, Bangladesh. Ninety (90) E. coli isolates were subjected to antibiotic susceptibility testing to determine their resistance. E. coli was confirmed via 16 S rRNA sequencing. PCR was employed for molecular analysis to screen extended-spectrum beta-lactamase (ESBL) genes and virulent genes linked to diarrheagenic E. coli. Genetic relatedness was assessed using Enterobacterial Repetitive Intergenic Consensus PCR (ERIC-PCR) to evaluate genomic diversity and potential clonal relationships. ETP isolates exhibited higher resistance than environmental isolates, with 93.10% showing β-lactam resistance (including 86.21% resistance to ampicillin) and 58.62% resistance to macrolides. In comparison, environmental isolates showed 67.21% β-lactam resistance and 57.38% macrolide resistance. Colistin and meropenem remained highly effective, with resistance detected in only 3.45% and 0% of ETP isolates, respectively, and 1.64% and 0% among environmental isolates. The blaNDM gene was most predominant in ETP isolates (79.31%), while the blaTEM gene was more frequent in environmental isolates (54.10%). Environmental isolates also carried ETEC virulence genes (eLT - 75.76%, eSTh - 63.64%) and the EPEC gene (eae - 45.45%). No virulence genes were found in ETP isolates. Phylogenetic analysis via ERIC-PCR revealed genetic clustering by location and resistance profile, suggesting localized resistance dissemination. Overall, this study reveals that pharmaceutical wastewater in Dhaka serves as a critical reservoir for MDR E. coli, with effluent treatment plant isolates showing higher antibiotic resistance, particularly to β-lactams, and harboring dominant resistance genes such as blaNDM. Moreover, environmental isolates carried key virulence genes such as eLT, eSTh, and eae, indicating localized dissemination and potential environmental spread of antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.